SAB BiotherapeuticsSABS
那斯達克 · USD
3.84
-0.23
(-5.65%)
盤中 03/04 12:36 (UTC+8)
03/04 12:36 (UTC+8)
SAB BiotherapeuticsSABS
3.84
-0.23
(-5.65%)
財務數據
損益表
- 0.00
- 0.01
- 0.00
- 0.01
- 0.00
- -
- 0.00
- -
- -
- -
- -85.20
- 1373.26
- -75.93
- 209.84
- -72.17
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | - | - | - | 115 | - | 263 | 945 | 305 | 1,267 | 86 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | 115 | - | 263 | 945 | 305 | 1,267 | 86 |
營業費用 | 12,679 | 9,732 | 10,772 | 10,124 | 11,310 | 10,465 | 12,335 | 19,178 | 6,591 | 6,562 |
研發費用 | 8,970 | 6,997 | 7,657 | 7,652 | 7,831 | 6,623 | 8,146 | 4,297 | 4,020 | 3,662 |
推銷及管理費用 | 3,709 | 2,735 | 3,115 | 2,472 | 3,479 | 3,842 | 4,189 | 14,881 | 2,571 | 2,900 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -12,679 | -9,732 | -10,772 | -10,009 | -11,309 | -10,202 | -11,391 | -18,874 | -5,323 | -6,477 |
其他收入及費用 | 58,168 | -318 | 5,645 | -1,315 | 1,038 | 2,959 | 6,441 | -3,905 | 290 | -329 |
利息費用 | 43 | 64 | 70 | 71 | 78 | 93 | 76 | 78 | 70 | 75 |
稅前純益 | 45,445 | -10,114 | -5,197 | -11,395 | -10,349 | -7,335 | -5,026 | -22,857 | -5,102 | -6,881 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | 45,445 | -10,114 | -5,197 | -11,395 | -10,349 | -7,335 | -5,026 | -22,857 | -5,102 | -6,881 |
基本每股稅後盈餘(元) | 0.50 | -1.09 | -0.56 | -1.23 | -1.12 | -0.79 | -0.54 | - | -0.10 | -0.14 |
稀釋每股稅後盈餘(元) | 1.32 | -1.09 | -0.56 | -1.23 | -1.11 | -0.80 | -0.54 | -0.38 | -0.10 | -0.14 |
基本平均股數(千股) | 10660.00 | 9294.00 | 9291.00 | 9292.00 | 9259.00 | 9255.00 | 9241.00 | - | 52406.00 | 50421.00 |
稀釋平均股數(千股) | 77863.00 | 9294.00 | 9291.00 | 9292.00 | 9259.00 | 9255.00 | 9241.00 | - | 52406.00 | 50421.00 |
還原基本每股稅後盈餘(元) | 0.50 | -1.09 | -0.56 | -1.23 | -1.12 | -0.79 | -0.54 | - | -0.97 | -1.36 |
還原稀釋每股稅後盈餘(元) | 1.32 | -1.09 | -0.56 | -1.23 | -1.11 | -0.80 | -0.54 | -3.85 | -0.97 | -1.36 |
還原基本平均股數(千股) | 10,660 | 9,294 | 9,291 | 9,292 | 9,259 | 9,255 | 9,241 | - | 5,240 | 5,042 |
還原稀釋平均股數(千股) | 77,863 | 9,294 | 9,291 | 9,292 | 9,259 | 9,255 | 9,241 | - | 5,240 | 5,042 |
EBITDA(千元) | 46,230 | -9,284 | -4,368 | -10,558 | -9,352 | -6,272 | -3,049 | -21,835 | -4,047 | -5,914 |